Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 22nd May 2019 from 11:00 AM to 1:00 PM (GMT).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 4, 2012
Previous Article Next Article

NF-κB as a potential therapeutic target in microbial diseases

Author affiliations

Abstract

The failure of conventional vaccines or antimicrobials to combat newly emerging pathogens such as new influenza viruses or antibiotic-resistant bacteria provides significant challenges in the identification of innovative therapeutic approaches and targets for microbial infections. Such therapies, directed towards host-cell molecules, may represent alternative options where conventional approaches face difficulties. We will largely focus on those strategies that directly target the host inflammatory response, specifically those that result in the activation of the nuclear transcription factor (NF)-κB. NF-κB plays a central role in the cellular stress response and in inflammation by controlling the expression of a network of inducers and effectors that define responses to pathogens. Therefore, the modulation of NF-κB activation and its signaling pathway offer an exceptional therapeutical strategy that could benefit from targeting a single host regulatory pathway. The use of NF-κB inhibitors or enhancers will be possible only if modulation between the host's and pathogen's advantage can be reached. Since different pathogens have developed various mechanisms to alter the activation of NF-κB, the present review will mainly focus on the role of NF-κB in microbial infections, highlighting its importance as a therapeutic target and reviewing the current understanding of how NF-κB inhibition can be considered a potential paradigm for the development of novel antimicrobial therapies.

Graphical abstract: NF-κB as a potential therapeutic target in microbial diseases

Back to tab navigation

Publication details

The article was received on 16 Aug 2011, accepted on 03 Jan 2012 and first published on 06 Feb 2012


Article type: Review Article
DOI: 10.1039/C2MB05335G
Mol. BioSyst., 2012,8, 1108-1120

  •   Request permissions

    NF-κB as a potential therapeutic target in microbial diseases

    M. Vitiello, M. Galdiero, E. Finamore, S. Galdiero and M. Galdiero, Mol. BioSyst., 2012, 8, 1108
    DOI: 10.1039/C2MB05335G

Search articles by author

Spotlight

Advertisements